U.S. Markets open in 2 hrs 11 mins

Kaskela Law LLC Announces Shareholder Investigation of Eidos Therapeutics, Inc. and Encourages Investors to Contact the Firm – EIDX

PHILADELPHIA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Kaskela Law LLC is investigating Eidos Therapeutics, Inc. (“Eidos”) (EIDX) on behalf of the company’s shareholders. 

The investigation seeks to determine whether Eidos and/or the company’s officers and directors have violated the securities laws, and whether Eidos shareholders have been harmed as a result of such actions. 

Eidos shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740, or by email at skaskela@kaskelalaw.com, to discuss this investigation and their legal rights and options.  Additional information may also be found at http://kaskelalaw.com/case/eidos-thera/.

Kaskela Law LLC exclusively represents investors in securities, corporate governance, and merger & acquisition litigation.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.  This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740
www.kaskelalaw.com
skaskela@kaskelalaw.com